MIT Research Suggests New Alzheimer's Treatment Approach Targeting Myelination

MIT scientists have identified a potential new therapeutic pathway for Alzheimer's disease, focusing on the APOE4 gene variant's impact on nerve cell insulation. Their research, published in Cell Stem Cell, indicates that restoring a disrupted molecular pathway by inhibiting GSK3b protein could improve myelination and potentially reverse damage. This discovery in human cells and mice offers a promising direction for future Alzheimer's treatment development.